2002Tianjin Yike Daxue xuebaoRequires access

Efficacy and safety of high-dose cisplatin with glulathione protection in the treatment of malignant tumors (A Report of 85 Cases)

Yan Liang

Open publisher page 0 citations

Abstract

Objective: To observe and evaluate the efficacy of glulathione in the treament of renal toxicity caused by cisplatin based chemotherapy.Methods: All the advanced malignancy cases were proved by pathology including None small cell lung cancer(27 cases),digestive cancer (39cases)and ovary carcinoma (19cases).The patients received combination chemotherapy based on high dose cisplatin.The dose of cisplatin was 70~80mg,d1~d3.(total 150mg~240mg).At the same time,glutathione was offered from d1-d3.The dose was 1.5g/m2 ,d1~d5 .Results : The response rate of combination chemotherapy with high dose cisplatin was over 50%,and the values of great,Bun,u-protein and electrolytes were normal .Conclusion: Glutathione has good protection on renal function.It can reduce the application of chemotherapy based on high dose cisplatin.

About this research paper

What this paper is about

Objective: To observe and evaluate the efficacy of glulathione in the treament of renal toxicity caused by cisplatin based chemotherapy.Methods: All the advanced malignancy cases were proved by pathology including None small cell lung cancer(27 cases),digestive cancer (39cases)and ovary carcinoma (19cases).The patients received combination chemotherapy based on high dose cisplatin.The dose of cisplatin was 70~80mg,d1~d3.(total 150mg~240mg).At the same time,glutathione was offered from d1-d3.The dose was 1.5g/m2 ,d1~d5 .Results : The response rate of combination chemotherapy with high dose cisplatin was over 50%,and the values of great,Bun,u-protein and electrolytes were normal .Conclusion: Glutathione has good protection on renal function.It can reduce the application of chemotherapy based on high dose cisplatin.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To observe and evaluate the efficacy of glulathione in the treament of renal toxicity caused by cisplatin based chemotherapy.Methods: All the advanced malignancy cases were proved by pathology including None small cell lung cancer(27 cases),digestive cancer (39cases)and ovary carcinoma (19cases).The patients received combination chemotherapy based on high dose cisplatin.The dose of cisplatin was 70~80mg,d1~d3.(total 150mg~240mg).At the same time,glutathione was offered from d1-d3.The dose was 1.5g/m2 ,d1~d5 .Results : The response rate of combination chemotherapy with high dose cisplatin was over 50%,and the values of great,Bun,u-protein and electrolytes were normal .Conclusion: Glutathione has good protection on renal function.It can reduce the application of chemotherapy based on high dose cisplatin.

Key concepts: Cisplatin, Medicine, Chemotherapy, Malignancy, Toxicity, Combination chemotherapy, Oncology, Lung cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy and safety of high-dose cisplatin with glulathione protection in the treatment of malignant tumors (A Report of 85 Cases) — Research Paper | ScholarLens